Status:
UNKNOWN
Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm
Lead Sponsor:
Peking University
Conditions:
Melanoma (Skin)
Melanoma in Situ
Eligibility:
All Genders
Brief Summary
The purpose of this study is to establish a standardized process for obtaining digital pathological image information of ocular tumors; use modern pathological techniques to obtain the co-expression i...
Detailed Description
This study is a prospective study. Patients with common and representative ocular tumors in the Department of Ophthalmology, Peking University Third Hospital, will be selected and enrolled after infor...
Eligibility Criteria
Inclusion
- Patients diagnosed with eye tumors and undergoing eye tumor surgery.
- Patients sign informed consent for sample collection and sample transfer agreement, and can cooperate with long-term regular follow-up requirements.
Exclusion
- Patients who are unable to undergo tumor surgery or retain samples due to various reasons .
- Patients who are positive for hepatitis B, HIV, and syphilis.
- Patient compliance is poor.
Key Trial Info
Start Date :
December 31 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04695015
Start Date
December 31 2020
End Date
June 1 2022
Last Update
January 5 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.